Latest News

Metabolic Health Tied to Lower Prediabetes Risk


 

TOPLINE:

Whether they have normal weight, overweight, or obesity, individuals with metabolically healthy (MH) phenotypes show a lower frequency of impaired glucose metabolism than their unhealthy counterparts across all weight categories.

METHODOLOGY:

  • The concepts of MH overweight and MH obesity refer to a subset of people who exhibit an absence of cardiometabolic risk factors despite excess body fat, but the prevalence of prediabetes has not been investigated by metabolic phenotype and body mass index (BMI).
  • This study first validated the use of estimated glucose disposal rate (eGDR), an index of insulin sensitivity calculated from clinical variables, in 350 individuals without diabetes (mean age, 37 years; 219 women; mean BMI, 30.3) from the EUGENE2 project who had varying glucose tolerance values originally assessed by insulin-stimulated glucose disposal.
  • Researchers then stratified 2201 participants without diabetes (mean age, 46 years; White; 1290 women; mean BMI, 31.2) from the CATAMERI study according to BMI into three groups — individuals with normal weight (BMI, 18-24.9), overweight (BMI, 25-29.9), and obesity (BMI, ≥ 30).
  • The men and women in each BMI group were separated into quartiles of insulin sensitivity based on eGDR index:
  • In the normal weight group, men and women were defined as MH in the top three eGDR quartiles and metabolically unhealthy (MU) in the lowest quartile.
  • In the overweight and obesity groups, people were defined as MH in the top eGDR quartile and MU in the lower three quartiles.
  • Impaired glucose tolerance (IGT), impaired fasting glucose (IFG), and combined IFG+IGT conditions (from an oral glucose tolerance test) were compared in individuals without diabetes based on MH or unhealthy phenotypes across normal weight, overweight, and obese categories.

TAKEAWAY:

  • eGDR demonstrated good accuracy in detecting individuals with higher insulin sensitivity in the EUGENE2 cohort.
  • The MH overweight and MH obesity groups showed comparable glycemic parameters as the MH normal weight group, whereas the MU overweight and MU obesity groups exhibited higher A1c levels and fasting and 2-hour post-load glucose than the MH normal weight group.
  • The frequencies of IFG, IGT, and IFG+IGT conditions were similar among the MH normal weight, MH overweight, and MH obesity groups but were higher in the MU overweight and MU obesity groups than in the MU normal weight group.
  • Furthermore, compared with those in the MH normal weight group, the odds of prediabetes were at least two times higher in the MU obesity (odds ratio [OR], 2.54; P < .001) and MU overweight (OR, 2.06; P < .001) groups but not significantly different in the MU normal weight, MH obesity, and MH overweight groups.

IN PRACTICE:

The authors wrote, “Overall, the results of this cross-sectional study support the notion that metabolically healthy individuals with overweight or obesity have a more favorable metabolic risk profile in comparison to metabolically unhealthy subjects with overweight or obesity.”

Pages

Recommended Reading

How Can Patients With Diabetes and Obesity Lose Weight?
MDedge Endocrinology
‘Ozempic Burgers’ Offer Indulgences to People With Obesity
MDedge Endocrinology
Semaglutide Improves Taste Sensitivity in Women With Obesity
MDedge Endocrinology
‘Don’t Screen’ for Vitamin D: New Endo Society Guideline
MDedge Endocrinology
Is Semaglutide the ‘New Statin’? Not So Fast
MDedge Endocrinology
Can Insulin Sensitivity Preserve Muscle During Weight Loss?
MDedge Endocrinology
New Oral Weight Loss Drugs: Where Are We and What’s Next?
MDedge Endocrinology
Is Cushing Syndrome More Common in the US Than We Think?
MDedge Endocrinology
Sugar Substitute Tied to Higher Risk for Heart Attack, Stroke
MDedge Endocrinology
Bariatric Surgery Beats GLP-1 RAs in Reducing Mortality Risk
MDedge Endocrinology